These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7942899)

  • 1. Reporting rates of adverse drug reactions.
    Rich DS
    Am J Hosp Pharm; 1994 Jul; 51(13):1710-1. PubMed ID: 7942899
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacists' role in reporting adverse drug reactions in an international perspective.
    van Grootheest K; Olsson S; Couper M; de Jong-van den Berg L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):457-64. PubMed ID: 15269929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of pharmacists to the reporting of adverse drug reactions.
    van Grootheest AC; van Puijenbroek EP; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2002; 11(3):205-10. PubMed ID: 12051119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connecticut Prescription Monitoring and Reporting System (CPMRS). How prescribers and pharmacists can help reduce prescription drug misuse and abuse.
    Conn Med; 2008 Aug; 72(7):439-40. PubMed ID: 18763674
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacovigilance: characteristics of the most widely used drugs in Bulgaria.
    Getov I; Dimitrova Z
    Cent Eur J Public Health; 1999 Aug; 7(3):133-6. PubMed ID: 10499144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.
    Ball D; Tisócki T
    Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of the pharmacist in reporting adverse drug reactions in the emergency department.
    Ratz Y; Shafir I; Berkovitch S; Sharristh M; Jacoby M; Kozer E; Golik A; Berkovitch M; Bar-Haim S
    J Clin Pharmacol; 2010 Oct; 50(10):1217-21. PubMed ID: 20418507
    [No Abstract]   [Full Text] [Related]  

  • 8. An ADR surveillance program: increasing quality, number of incidence reports.
    Orsini MJ; Orsini PA; Thorn DB; Gallina JN
    Formulary; 1995 Aug; 30(8):454-61. PubMed ID: 10151733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Joint program of pharmacovigilance in Quebec: comparison with France, Aquitaine and the Basque region].
    Biron P; Balency D
    Therapie; 1996; 51(5):578-81. PubMed ID: 9138400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adverse drug reaction: a clinical opportunity for pharmacists.
    Miller JD
    Hosp Pharm; 1995 Sep; 30(9):769-73. PubMed ID: 10151281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs.
    Jarernsiripornkul N; Krska J; Pongmanachai M; Nasritha N
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):837-41. PubMed ID: 19548223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive monitoring of new drugs based on first prescription signals from pharmacists: a pilot study.
    van Grootheest AC; Groote JK; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2003 Sep; 12(6):475-81. PubMed ID: 14513661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centre for Adverse Reactions Monitoring report for the year ending 30 June, 1994.
    Pillans PI; Coulter DM
    N Z Med J; 1995 Nov; 108(1012):488-91. PubMed ID: 8538979
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug monitoring in Tunisia: organization and objectives].
    Daghfous R; Elaidi S; Loueslati MH; Srairi S; Lakhal M; Belkahia C
    Tunis Med; 1994 Feb; 72(2):83-6. PubMed ID: 7974826
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse drug reaction monitoring in India.
    Kshirsagar NA; Karande SC; Potkar CN
    J Assoc Physicians India; 1993 Jun; 41(6):374-6. PubMed ID: 8005977
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
    Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
    Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adverse drug reaction reporting and drug monitoring].
    Harg P; Lislevand H; Buajordet I; Madsen S
    Tidsskr Nor Laegeforen; 2003 Feb; 123(3):331-2. PubMed ID: 12640902
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring vaccine safety depends on reports from providers.
    Grabenstein JD
    J Am Pharm Assoc (Wash); 1999; 39(6):869. PubMed ID: 10609455
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway.
    Granas AG; Buajordet M; Stenberg-Nilsen H; Harg P; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):429-34. PubMed ID: 16953518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.